RSV is often associated with infants and young children, but it can also cause serious illness in older adults and other vulnerable populations. In this episode, we explore effective strategies for communicating the burden of RSV disease to patients and caregivers and discuss how education about RSV vaccines and monoclonal antibodies can help overcome barriers to prevention and protection.
Monica Mahoney, PharmD, BCPS, BCIDP, FCCP, FIDSA, FIDP, FMSHP is a clinical pharmacy specialist in the outpatient infectious diseases and outpatient parenteral antibiotic therapy (OPAT) clinics at Beth Israel Deaconess Medical Center in Boston, Massachusetts. Dr. Mahoney received her PharmD degree from MCPHS University in Boston, Massachusetts. She completed postgraduate year 1 residency and postgraduate year 2 infectious diseases residency at Tufts Medical Center in Boston, Massachusetts. She is an active member of many pharmacy and infectious diseases professional organizations, including ASHP, the Society of Infectious Diseases Pharmacists, the Infectious Diseases Society of America, and the Society for Healthcare Epidemiology of America. She is an associate editor at Open Forum Infectious Diseases (OFID), section editor at Contagion Live, and on the editorial board for Antimicrobial Stewardship & Hospital Epidemiology (ASHE).
Sarah Parsons, PharmD, BCPPS, FPPA is a clinical pharmacy specialist in pediatric infectious diseases and the co-lead of the antimicrobial stewardship program at the Children’s Hospital of The King’s Daughters in Norfolk, Virginia. Dr. Parsons received her Doctor of Pharmacy degree from Virginia Commonwealth University School of Pharmacy. She completed a PGY-1 residency with pediatric focus at HCA Healthcare in Richmond, Virginia. Dr. Parsons specializes in the treatment of multi-drug resistant gram negative infections, nontuberculous mycobacterium in cystic fibrosis, COVID/MIS-C, and vaccine preventable diseases in children. She is an active member of many pharmacy, pediatric, and infectious diseases professional organizations, including ASHP, the Pediatric Infectious Diseases Society, the Society of Infectious Diseases Pharmacists, the American College of Clinical Pharmacy, and is a 2025 fellow of the Pediatric Pharmacy Association.
On-Demand Webinar: Time to RSVP to RSV Prevention: Severe RSV Disease Burden and the Evidence Supporting RSV Vaccination and Monoclonal Antibodies
The following person in control of this activity’s content has relevant financial relationships:
All other persons in control of content do not have any relevant financial relationships with an ineligible company.
As defined by the Standards of Integrity and Independence in Accredited Education definition of ineligible company. All relevant financial relationships have been mitigated prior to the CE activity.
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.
